Clinical effectiveness and safety of vildagliptin in >19 000 patients with type 2 diabetes: the GUARD study.

Rosales R, E Abou Jaoude, M Al-Arouj, A Fawwad, A Orabi, P Shah, S DiTommaso, J Vaz

https://www.ncbi.nlm.nih.gov/pubmed/25586779

Diabetes Obes Metab. 2015 Jun;17(6):603-7. doi: 10.1111/dom.12436. Epub 2015 Feb 6.

PMID:25586779DOI:10.1111/dom.12436